in partnership with the World Health Organization (WHO)
About this session
Antimicrobial resistant infections (AMR) are on the rise and pose a significant global risk. Developing countries, in particular, are vulnerable because they often lack key medical resources. The development of new antibacterial treatments is costly while the return on investment is low. Organized in cooperation with the World Health Organization (WHO), the conference will explore solutions to this dilemma, seeking to facilitate cooperation between biotech firms, potential investors and governments for AMR investment. It will present some innovative technologies that need financial support and provide a matchmaking platform to connect impact investors with researchers and developers of treatments against AMR.
Issues for the debate
- What is the role of governments?
- What are the needs of the industry?
- Which innovative means of investment can help address the AMR problem?
Speakers
Hon. Dr. Alfred Madigele
Minister of Health and Wellness, Botswana
H.E. Dr. Venko Filipche
Minister of Health, former Yugoslav Republic of Macedonia
Dr. Ranieri Guerra
Assistant Director General for Special Initiatives, World Health Organisation
Dr. Yoshinori Yamano
Chief Scientific Officer for Infectious Diseases Pharmaceutical Research Division SHIONOGI & CO., LTD.
Dr. Rich Lawson
CARB-X Senior Project Manager, Boston University School of Law
Dr. Laura Piddock
Head of Scientific Affairs, Global Antibiotic Research and Development Partnership (GARDP)
Dr. Andreas Sandgren
Policy Advisor, ReAct - Action on Antibiotic Resistance Uppsala University, Sweden
Dr. Clemens Martin Auer
Director-General, Federal Ministry of Labour, Social Affairs, Health and Consumer Protection, Austria
Mr. Tomotaka Goji
Managing Partner, The University of Tokyo Edge Capital Japan Fund
Dr. Niresh Bhagwandin
Executive Manager of Strategic Research Initiatives, South Africa Medical Research Council
Mr. Kees de Joncheere
Chairman, Netherlands Antibiotic Development Platform
Mr. Christopher Egerton-Warburton
Expert Advisory Board Chair, United Kingdom Global AMR Innovation Fund
Dr. Anand Anandkumar
CEO, Bugworks Research
Dr. Marc Gitzinger
CEO, Bioversys
Ms. Jenny Hellman
Public Health Agency of Sweden
Ms. Isabelle Durant
Deputy Secretary-General, United Nations Conference on Trade and Development
Mr. Virander Paul
Ambassador/Deputy Permanent Representative of India to the UN
Mr. Jean-Pierre Paccaud
the Incubation Business Development & Strategy Director, GARDP